Can Contemporary Patients with Biopsy Gleason Score 3+4 Be Eligible for Active Surveillance?

INTRODUCTION: We analyzed whether expansion of existing active surveillance (AS) protocols to include men with biopsy Gleason score (GS) 3+4 prostate cancer (PCa) would significantly alter pathologic and biochemical outcomes of potential candidates of AS. METHODS: Among patients who underwent radica...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwon, Ohseong, Kim, Tae Jin, Lee, In Jae, Byun, Seok-Soo, Lee, Sang Eun, Hong, Sung Kyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4182658/
https://www.ncbi.nlm.nih.gov/pubmed/25268898
http://dx.doi.org/10.1371/journal.pone.0109031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4182658/
https://www.ncbi.nlm.nih.gov/pubmed/25268898
http://dx.doi.org/10.1371/journal.pone.0109031

Ejemplares similares